Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis

This publication has 61 references indexed in Scilit:

• Henoch-Schonlein purpura and meningococcal B vaccination
  Archives of Disease in Childhood, 2009
• The Intensive Vaccines Monitoring Programme (IVMP): An electronic system to monitor vaccine safety in New Zealand
  Vaccine, 2008
• Use of available outer membrane vesicle vaccines to control serogroup B meningococcal outbreaks
  Vaccine, 2007
• Immunogenicity of a combination vaccine containing pneumococcal conjugates and meningococcal PorA OMVs
  Vaccine, 2007
• Persisting Immune Responses Indicating Long-Term Protection after Booster Dose with Meningococcal Group B Outer Membrane Vesicle Vaccine
  Clinical and Vaccine Immunology, 2006
• The VR2 Epitope on the PorA P1.7-2,4 Protein Is the Major Target for the Immune Response Elicited by the Strain-Specific Group B Meningococcal Vaccine MeNZB
  Clinical and Vaccine Immunology, 2006
• Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis
  Vaccine, 2005
• The concept of ?tailor-made?, protein-based, outer membrane vesicle vaccines against meningococcal disease
  Vaccine, 2005
• Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants
  The Journal of Pediatrics, 1992
• IMMUNOGENICITY IN INFANTS OF HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE IN A CONJUGATE VACCINE WITH NEISSERIA MENINGITIDIS OUTER-MEMBRANE PROTEIN
  The Lancet, 1986